Dimitri Sarantakis

455 total citations
16 papers, 341 citations indexed

About

Dimitri Sarantakis is a scholar working on Molecular Biology, Organic Chemistry and Cellular and Molecular Neuroscience. According to data from OpenAlex, Dimitri Sarantakis has authored 16 papers receiving a total of 341 indexed citations (citations by other indexed papers that have themselves been cited), including 9 papers in Molecular Biology, 5 papers in Organic Chemistry and 4 papers in Cellular and Molecular Neuroscience. Recurrent topics in Dimitri Sarantakis's work include Chemical Synthesis and Analysis (8 papers), Neuropeptides and Animal Physiology (4 papers) and Receptor Mechanisms and Signaling (3 papers). Dimitri Sarantakis is often cited by papers focused on Chemical Synthesis and Analysis (8 papers), Neuropeptides and Animal Physiology (4 papers) and Receptor Mechanisms and Signaling (3 papers). Dimitri Sarantakis collaborates with scholars based in United States and Canada. Dimitri Sarantakis's co-authors include Eric L. Lien, Richard L. Fenichel, Norman H. Grant, John P. Yardley, Theodore Foell, A. L. Ungar, G. Ungar, David H. Malin, Mack Kuo and David A. Fidock and has published in prestigious journals such as Nature, Diabetes and Biochemical and Biophysical Research Communications.

In The Last Decade

Dimitri Sarantakis

15 papers receiving 288 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name	h						Papers	Cites
Dimitri Sarantakis United States	10	197	118	54	51	38	16	341
Béatrice Bonnet France	12	149 0.8×	129 1.1×	57 1.1×	63 1.2×	14 0.4×	24	440
Erli You China	8	155 0.8×	31 0.3×	16 0.3×	62 1.2×	16 0.4×	11	329
Giulio Galliani Italy	14	148 0.8×	150 1.3×	7 0.1×	29 0.6×	16 0.4×	40	391
Karen M. Grimm United States	6	201 1.0×	59 0.5×	17 0.3×	23 0.5×	3 0.1×	7	432
Takeshi Mise Japan	6	197 1.0×	37 0.3×	112 2.1×	10 0.2×	48 1.3×	8	324
Kaoru Ito Japan	8	166 0.8×	57 0.5×	23 0.4×	17 0.3×	8 0.2×	19	419
Steven G. Kultgen United States	7	87 0.4×	75 0.6×	42 0.8×	20 0.4×	9 0.2×	15	201
Anne‐Marie Cathiard France	10	139 0.7×	23 0.2×	9 0.2×	19 0.4×	99 2.6×	19	473
Annika Petersson Sweden	9	158 0.8×	24 0.2×	6 0.1×	33 0.6×	20 0.5×	15	346
Alain Pellet France	8	144 0.7×	195 1.7×	9 0.2×	88 1.7×	4 0.1×	9	410

Countries citing papers authored by Dimitri Sarantakis

Since Specialization

Citations

This map shows the geographic impact of Dimitri Sarantakis's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Dimitri Sarantakis with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Dimitri Sarantakis more than expected).

Fields of papers citing papers by Dimitri Sarantakis

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Dimitri Sarantakis. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Dimitri Sarantakis. The network helps show where Dimitri Sarantakis may publish in the future.

Co-authorship network of co-authors of Dimitri Sarantakis

This figure shows the co-authorship network connecting the top 25 collaborators of Dimitri Sarantakis. A scholar is included among the top collaborators of Dimitri Sarantakis based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Dimitri Sarantakis. Dimitri Sarantakis is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

16 of 16 papers shown

Anderson, John W., Dimitri Sarantakis, Jacek Terpiński, et al.. (2012). Novel diaryl ureas with efficacy in a mouse model of malaria. Bioorganic & Medicinal Chemistry Letters. 23(4). 1022–1025. 21 indexed citations

Freundlich, Joel S., John W. Anderson, Dimitri Sarantakis, et al.. (2005). Synthesis, biological activity, and X-ray crystal structural analysis of diaryl ether inhibitors of malarial enoyl acyl carrier protein reductase. Part 1: 4′-Substituted triclosan derivatives. Bioorganic & Medicinal Chemistry Letters. 15(23). 5247–5252. 63 indexed citations

Huryn, Donna M., Susan Ashwell, Andrei W. Konradi, et al.. (2004). Synthesis, characterization and evaluation of pro-drugs of VLA-4 antagonists. Bioorganic & Medicinal Chemistry Letters. 14(7). 1651–1654. 6 indexed citations

Sarantakis, Dimitri, et al.. (1997). Solid phase synthesis of sec-amides and removal from the polymeric support under mild conditions. Tetrahedron Letters. 38(42). 7325–7328. 38 indexed citations

Bender, Reinhold H. W. & Dimitri Sarantakis. (1986). SYNTHESIS OF 3-CARBOXYTHIOPHENE-2-ACETIC ACID AND ITS DERIVATIVES. Organic Preparations and Procedures International. 18(4). 286–289.

Bex, Frederick J., Alan Corbin, Dimitri Sarantakis, & Eric L. Lien. (1980). Luteinising hormone-releasing and anti-fertility properties of a glucagon-selective somatostatin analogue. Nature. 284(5754). 342–343. 4 indexed citations

Lien, Eric L., J. Greenwood, & Dimitri Sarantakis. (1979). Treatment of Streptozotocin-Diabetic Dogs With a Long-Acting Somatostatin Analog. Diabetes. 28(5). 491–495. 9 indexed citations

Corbin, A., et al.. (1979). Agonist (Ovulation Induction) and Post-Coital Contraceptive Properties of [D-Ala⁶] and [D-Trp⁶]-Lhrh Series. Endocrine Research Communications. 6(1). 1–14. 7 indexed citations

Ungar, G., A. L. Ungar, David H. Malin, & Dimitri Sarantakis. (1977). Brain peptides with opiate antagonist action: Their possible role in tolerance and dependence. Psychoneuroendocrinology. 2(1). 1–10. 29 indexed citations

10.

Corbin, Alan, Craig W. Beattie, R. W. Rees, et al.. (1977). Postcoital Contraceptive Effects Of Agonist Analogs Of Luteinizing Hormone-Releasing Hormone. Fertility and Sterility. 28(4). 471–475. 31 indexed citations

11.

Sarantakis, Dimitri, et al.. (1976). A novel cyclic undecapeptide, Wy-40,770, with prolonged growth hormone release inhibiting activity. Biochemical and Biophysical Research Communications. 73(2). 336–342. 58 indexed citations

12.

Beattie, Craig W., A. Corbin, Theodore Foell, et al.. (1976). ChemInform Abstract: LUTEINIZING HORMONE‐RELEASING HORMONE. ANTIOVULATORY ACTIVITY OF ANALOGS SUBSTITUTED IN POSITIONS 2 AND 6. Chemischer Informationsdienst. 7(14). 1 indexed citations

13.

Sarantakis, Dimitri, et al.. (1976). STRUCTURE ACTIVITY STUDIES ON SOMATOSTATIN. Clinical Endocrinology. 5(s1). 275S–278S. 31 indexed citations

14.

Beattie, Craig W., A. Corbin, Theodore Foell, et al.. (1975). Luteinizing hormone-releasing hormone. Antiovulatory activity of analogs substituted in positions 2 and 6. Journal of Medicinal Chemistry. 18(12). 1247–1250. 18 indexed citations

15.

Sarantakis, Dimitri, et al.. (1973). The synthesis and biological activity of Ala3, 14-somatostatin. Biochemical and Biophysical Research Communications. 55(2). 538–542. 4 indexed citations

16.

Sarantakis, Dimitri, et al.. (1973). Total synthesis of hypothalamic “somatostatin”. Biochemical and Biophysical Research Communications. 54(1). 234–238. 21 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact